{"id":"W2173572264","doi":"10.1093/annonc/mdv324","title":"A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma","year":2015,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"ca_institutions":"London Health Sciences Centre","funders":"National Cancer Institute; Celgene","keywords":"Dacarbazine; Medicine; Paclitaxel; Internal medicine; Clinical endpoint; Hazard ratio; Chemotherapy; Melanoma; Neutropenia; Oncology; Randomized controlled trial; Gastroenterology; Progression-free survival; Confidence interval; Urology; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001438076,0.0001724901,0.002295285,0.0003183302,0.00001154312,0.00000330127,0.00007946004,0.00008196147,0.0001225542],"category_scores_gemma":[0.0008887438,0.0001166407,0.0002480128,0.0002148537,0.00018213,0.00004005959,0.00002531417,0.0001196956,0.00000563888],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006086815,"about_ca_system_score_gemma":0.0002424451,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001452365,"about_ca_topic_score_gemma":0.00008501553,"domain_scores_codex":[0.9979663,0.0003661094,0.0008943067,0.000202657,0.0003490255,0.0002216094],"domain_scores_gemma":[0.9980217,0.0005955042,0.0005994353,0.0002392224,0.0004045355,0.0001396461],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9789918,0.003824818,0.00004857248,0.00003454876,0.001272324,0.00007351797,0.0005687532,0.000009593501,0.00005661397,0.0001977993,0.001263415,0.01365824],"study_design_scores_gemma":[0.95704,0.03388352,0.00003570638,0.0000336405,0.0004707701,0.00001005888,0.000340394,0.0001933676,0.0003484663,0.0001030382,0.00744886,0.00009223559],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9770244,0.0002061715,0.00009536476,0.001571244,0.0004474059,0.004060199,0.000008962403,0.00001645739,0.01656975],"genre_scores_gemma":[0.9982055,0.00009854136,0.0003420268,0.0005030337,0.00006428158,0.000192971,0.00002466041,0.0000169754,0.0005519725],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0300587,"threshold_uncertainty_score":0.4756471,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07239729487824467,"score_gpt":0.3808896184690667,"score_spread":0.308492323590822,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}